Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy

被引：0
|
作者：
Sestak, Ivana
Regan, Meredith
Dodson, Andrew
Viale, Giuseppe
Thurlimann, Beat
Colleoni, Marco
Cuzick, Jack
Dowsett, Mitch
机构：
[1] QMUL, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Ralph Lauren Ctr Breast Canc Res, London, England
[4] European Inst Oncol, Milan, Italy
[5] Kantonsspital St Gallen, St Gallen, Switzerland
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GS6-01
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Oestrogen receptor variant expression as potential selectors for adjuvant endocrine therapy in breast cancer patients
    Green, AR
    Paish, EC
    Gee, JM
    Nicholson, RI
    Cheung, KL
    Robertson, JF
    Ellis, IO
    JOURNAL OF PATHOLOGY, 2005, 205 : 5 - 5
  • [32] Selection of primary breast cancer patients for adjuvant endocrine therapy - is oestrogen receptor alone adequate?
    Cheung, KL
    Nicholson, RI
    Blamey, RW
    Robertson, JFR
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) : 155 - 162
  • [33] Prediction of distant recurrence by EndoPredict in patients with estrogen receptor-positive, HER2-negative breast cancer who received adjuvant endocrine therapy plus chemotherapy (ET plus C) or endocrine therapy alone (ET)
    Sestak, I.
    Martin, M.
    Dubsky, P.
    Rojo, F.
    Cuzick, J.
    Filipits, M.
    Ruiz, A.
    Buus, R.
    Hlauschek, D.
    Rodriguez-Lescure, A.
    Dowsett, M.
    Gnant, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] Integration of tumor size and grade with the breast cancer index (BCI) for prediction of distant recurrence in hormone receptor-positive breast cancer with 1-3 positive lymph nodes
    Sestak, I.
    Zhang, Y.
    Schroeder, B.
    Dowsett, M.
    Sgroi, D.
    Cuzick, J.
    Schnabel, C. A.
    CANCER RESEARCH, 2016, 76
  • [35] Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer
    Lim, Seung Taek
    Jeon, Ye Won
    Gwak, Hongki
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 498 - 508
  • [36] Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy
    Ito, Masahiro
    Amari, Masakazu
    Sato, Akiko
    Hikichi, Masahiro
    Sakamoto, Aru
    Yamazaki, Asumi
    Saji, Shigehira
    BREAST, 2024, 73
  • [37] Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence
    Murata, Takeshi
    Jinno, Hiromitsu
    Takahashi, Maiko
    Shimoda, Masayuki
    Hayashida, Tetsu
    Kameyama, Kaori
    Kitagawa, Yuko
    BREAST JOURNAL, 2019, 25 (01): : 9 - 15
  • [38] Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population (vol 14, pg 1067, 2013)
    Sgroi, D. C.
    Sestak, I
    Cuzick, J.
    LANCET ONCOLOGY, 2018, 19 (04): : E184 - E184
  • [39] PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer
    Laenkholm, Anne-Vibeke
    Jensen, Maj-Britt
    Eriksen, Jens Ole
    Rasmussen, Birgitte Bruun
    Knoop, Ann S.
    Buckingham, Wesley
    Ferree, Sean
    Schaper, Carl
    Nielsen, Torsten O.
    Haffner, Taryn
    Kibol, Torben
    Talman, Maj-Lis Moller
    Jylling, Anne Marie Bak
    Tabor, Tomasz Piotr
    Ejlertsen, Bent
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 735 - +
  • [40] Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
    Takada, Koji
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Kouhashi, Rika
    Yabumoto, Akimichi
    Ishihara, Sae
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    BMC WOMENS HEALTH, 2021, 21 (01)
12345